JP2025512771A5 - - Google Patents
Info
- Publication number
- JP2025512771A5 JP2025512771A5 JP2024555941A JP2024555941A JP2025512771A5 JP 2025512771 A5 JP2025512771 A5 JP 2025512771A5 JP 2024555941 A JP2024555941 A JP 2024555941A JP 2024555941 A JP2024555941 A JP 2024555941A JP 2025512771 A5 JP2025512771 A5 JP 2025512771A5
- Authority
- JP
- Japan
- Prior art keywords
- rnai construct
- construct according
- antisense strand
- sense strand
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263322845P | 2022-03-23 | 2022-03-23 | |
| US63/322,845 | 2022-03-23 | ||
| PCT/US2023/064765 WO2023183801A2 (en) | 2022-03-23 | 2023-03-21 | Rnai constructs for inhibiting pnpla3 expression and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512771A JP2025512771A (ja) | 2025-04-22 |
| JP2025512771A5 true JP2025512771A5 (https=) | 2026-03-30 |
Family
ID=88102183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024555941A Pending JP2025512771A (ja) | 2022-03-23 | 2023-03-21 | ＰＮＰＬＡ３発現を阻害するためのＲＮＡｉコンストラクト及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250207138A1 (https=) |
| EP (1) | EP4496893A2 (https=) |
| JP (1) | JP2025512771A (https=) |
| KR (1) | KR20240162559A (https=) |
| CN (1) | CN118891364A (https=) |
| AR (1) | AR128877A1 (https=) |
| AU (1) | AU2023237880A1 (https=) |
| CA (1) | CA3254112A1 (https=) |
| CL (1) | CL2024002802A1 (https=) |
| IL (1) | IL315078A (https=) |
| MX (1) | MX2024011595A (https=) |
| TW (1) | TW202345869A (https=) |
| WO (1) | WO2023183801A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025252063A1 (zh) * | 2024-06-04 | 2025-12-11 | 正大天晴药业集团股份有限公司 | 靶向pnpla3的双链核糖核酸 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2976445A1 (en) * | 2015-02-13 | 2016-08-18 | Alnylam Pharmaceuticals, Inc. | Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof |
| TW202542311A (zh) * | 2018-09-19 | 2025-11-01 | 美商Ionis製藥公司 | Pnpla3表現之調節劑 |
-
2023
- 2023-03-21 IL IL315078A patent/IL315078A/en unknown
- 2023-03-21 JP JP2024555941A patent/JP2025512771A/ja active Pending
- 2023-03-21 CN CN202380028634.5A patent/CN118891364A/zh active Pending
- 2023-03-21 KR KR1020247034728A patent/KR20240162559A/ko active Pending
- 2023-03-21 CA CA3254112A patent/CA3254112A1/en active Pending
- 2023-03-21 EP EP23775843.8A patent/EP4496893A2/en active Pending
- 2023-03-21 WO PCT/US2023/064765 patent/WO2023183801A2/en not_active Ceased
- 2023-03-21 AU AU2023237880A patent/AU2023237880A1/en active Pending
- 2023-03-21 US US18/848,796 patent/US20250207138A1/en active Pending
- 2023-03-23 TW TW112110948A patent/TW202345869A/zh unknown
- 2023-03-23 AR ARP230100734A patent/AR128877A1/es unknown
-
2024
- 2024-09-17 CL CL2024002802A patent/CL2024002802A1/es unknown
- 2024-09-20 MX MX2024011595A patent/MX2024011595A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024105284A5 (https=) | ||
| JP4718379B2 (ja) | 修飾された低分子干渉ｒｎａ分子および使用方法 | |
| TWI880645B (zh) | 抑制lpa之基因表現之組合物及方法 | |
| JP2023537943A5 (https=) | ||
| JP2022511550A5 (https=) | ||
| JP2022078069A (ja) | 二本鎖ＲＮＡによるα－１アンチトリプシンの特異的阻害のための方法及び組成物 | |
| US12303525B2 (en) | Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection | |
| JP2011505833A5 (https=) | ||
| CN116514890A (zh) | 用于B型肝炎病毒感染的RNAi剂 | |
| EP1353935A2 (en) | Selection of catalytic nucleic acids targeted to infectious agents | |
| JP2009514877A5 (https=) | ||
| JP2009513144A5 (https=) | ||
| JP2008523157A5 (https=) | ||
| CN113507920A (zh) | 用于乙型肝炎病毒感染的RNAi剂 | |
| CA3189861A1 (en) | Dux4 inhibitors and methods of use thereof | |
| JP2010538660A (ja) | ＳＴＡＴ３ｓｉＲＮＡ含有組成物及びそれらの使用法 | |
| JP2010532163A5 (https=) | ||
| JP2014508161A (ja) | 肺疾患および損傷を治療するための組成物および方法 | |
| JP2022534402A5 (https=) | ||
| JP2009531433A5 (https=) | ||
| JP2024538859A5 (https=) | ||
| JP2023506546A (ja) | Ｂ型肝炎ウイルス感染症を処置するためのｓｅｐｔ９阻害剤の使用 | |
| JP2025512771A5 (https=) | ||
| JP2023553610A5 (https=) | ||
| JP2023538630A (ja) | Ｂ型肝炎ウイルス感染症を処置するためのａ１ｃｆ阻害剤の使用 |